Inventor · disambiguated record
Lauge Schaffer
Also filed as: SCHAEFFER LAUGE · SCHAFFER LAUGE · SCHÄFFER LAUGE
7 granted patents·14 pending applications·198 citations·filing 1997–2010
87Inventor score
Top patents by PatentIndex Score
21 records- 0192US7316999B2Glucose dependent release of insulin from glucose sensing insulin derivativesNOVO NORDISK AS·Filed 2001·Granted Jan 8, 2008·42 cites·26 claims
- 0290US8895694B2Glucagon-Like Peptide-1 derivatives and their pharmaceutical useSPETZLER JANE·Filed 2008·Granted Nov 25, 2014·29 cites·11 claims
- 0390US6875741B2Insulin and IGF-1 receptor agonists and antagonistsFiled 2001·Granted Apr 5, 2005·69 cites·30 claims
- 0486US8603972B2Extended GLP-1 compoundsLAU JESPER·Filed 2006·Granted Dec 10, 2013·11 cites·25 claims
- 0578US8895504B2Amylin derivativesSCHÄFFER LAUGE·Filed 2009·Granted Nov 25, 2014·7 cites·11 claims
- 0678US8486890B2Amylin derivativesHANSEN THOMAS KRUSE·Filed 2007·Granted Jul 16, 2013·6 cites·9 claims
- 0776US6451970B1Peptide derivativesNOVO NORDISK AS·Filed 1997·Granted Sep 17, 2002·34 cites·4 claims
- 0865US2009192072A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 0961US2007265189A1Insulin and igf-1 receptor agonists and antagonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1058US2011039779A1Igf-1r binding proteins and antagonistsOSTERGAARD SOREN·Filed 2008·Application pending·0 cites
- 1158US2010292133A1Truncated glp-1 derivaties and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1258US2010261637A1Peptides derivatized with a-b-c-d- and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1357US2003236190A1Isulin and IGF-1 receptor agonists and antagonistsFiled 2002·Application pending·0 cites
- 1455US2009318353A1Acylated Exendin-4 CompoundsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1555US2003171535A1Peptide derivativesFiled 2002·Application pending·0 cites
- 1653US2011124556A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 1752US2011152183A1Derivatised hybrid peptides of amylin and salmon calcitoninNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 1850US2010222269A1Improved derivatives of amylinNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1941US2010298213A1Pharmaceutically Active Insulin Receptor-Modulating MoleculesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2041US2009197800A1Insulin Receptor Binding Peptides with Non-Insulin Gene Activation Profiles and Uses ThereofNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2139US2009197805A1Insulin receptor antagonists and related compositions, uses and methodsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →